Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 1081 AL 1095

P2Y receptors in Alzheimer's disease

Erb L, Cao C, Ajit D, Weisman GA.

Biol Cell. 2015 Jan;107(1):1-21. doi: 10.1111/boc.201400043. Epub 2014 Oct 13.

The Role of PICALM in Alzheimer's Disease

Xu W, Tan L, Yu JT.

Mol Neurobiol. 2015 Aug;52(1):399-413. doi: 10.1007/s12035-014-8878-3. Epub 2014 Sep 4.

QT prolongation associated with memantine in Alzheimer's disease

Takehara H, Suzuki Y, Someya T.

Psychiatry Clin Neurosci. 2015 Apr;69(4):239-40. doi: 10.1111/pcn.12236. Epub 2014 Oct 9.

Confirmatory population pharmacokinetic analysis for bapineuzumab phase 3 studies in patients with mild to moderate Alzheimer's disease

Hu C, Adedokun O, Ito K, Raje S, Lu M.

J Clin Pharmacol. 2015 Feb;55(2):221-9. doi: 10.1002/jcph.393. Epub 2014 Sep 16.

Eph receptors: new players in Alzheimer's disease pathogenesis

Cissé M, Checler F.

Neurobiol Dis. 2015 Jan;73:137-49. doi: 10.1016/j.nbd.2014.08.028. Epub 2014 Sep 1.

Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery

Sarvaiya J, Agrawal YK.

Int J Biol Macromol. 2015 Jan;72:454-65. doi: 10.1016/j.ijbiomac.2014.08.052. Epub 2014 Sep 6.

Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD)

Zhao Y, Bhattacharjee S, Jones BM, Hill JM, Clement C, Sambamurti K, Dua P, Lukiw WJ.

Mol Neurobiol. 2015 Aug;52(1):533-44. doi: 10.1007/s12035-014-8886-3. Epub 2014 Sep 10.

Assessment of regional gray matter loss in dementia with Lewy bodies: a surface-based MRI analysis

Watson R, Colloby SJ, Blamire AM, O'Brien JT.

Am J Geriatr Psychiatry. 2015 Jan;23(1):38-46. doi: 10.1016/j.jagp.2014.07.005. Epub 2014 Jul 23.

Trajectories of cognitive decline in different types of dementia

Smits LL, van Harten AC, Pijnenburg YA, Koedam EL, Bouwman FH, Sistermans N, Reuling IE, Prins ND, Lemstra AW, Scheltens P, van der Flier WM.

Psychol Med. 2015 Apr;45(5):1051-9. doi: 10.1017/S0033291714002153. Epub 2014 Sep 17.

Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants

Di Domenico F, Barone E, Perluigi M, Butterfield DA.

Expert Rev Neurother. 2015 Jan;15(1):19-40. doi: 10.1586/14737175.2015.955853. Epub 2014 Sep 22.

[Alzheimer's disease: New therapeutic strategies]

Villegas S.

Med Clin (Barc). 2015 Jul 20;145(2):76-83. doi: 10.1016/j.medcli.2014.05.023. Epub 2014 Sep 20.

Measuring brain atrophy with a generalized formulation of the boundary shift integral

Prados F, Cardoso MJ, Leung KK, Cash DM, Modat M, Fox NC, Wheeler-Kingshott CA, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2015 Jan;36 Suppl 1(Suppl 1):S81-90. doi: 10.1016/j.neurobiolaging.2014.04.035. Epub 2014 Aug 29.

Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition

Ishii K, Hosokawa C, Hyodo T, Sakaguchi K, Usami K, Shimamoto K, Hosono M, Yamazoe Y, Murakami T.

Ann Nucl Med. 2015 Jan;29(1):78-83. doi: 10.1007/s12149-014-0911-0. Epub 2014 Oct 1.

Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer's disease

González-Domínguez R, García-Barrera T, Gómez-Ariza JL.

Talanta. 2015 Jan;131:480-9. doi: 10.1016/j.talanta.2014.07.075. Epub 2014 Aug 21.

Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy

Latta CH, Brothers HM, Wilcock DM.

Neuroscience. 2015 Aug 27;302:103-11. doi: 10.1016/j.neuroscience.2014.09.061. Epub 2014 Oct 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias